Skip to main content
Log in

Distribution of 3H-soman in mice

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

3H-soman (specific activity 10 Ci/mMol), a potent irreversible cholinesterase inhibitor, was administered IV to mice in a dose of one LD-50, which corresponds to 0.25 mCi/mouse. Animals were sacrificed at 5 min, 2 h and 24 h, and whole body autoradiography was performed. High levels of radioactivity in lung and skin were observed at all time intervals after injection. The central nervous system showed very low concentrations of radioactivity, which remained so for 24 h post-injection. Considerable accumulation of 3H-soman in the urine and gallbladder, and in the intestinal lumen, may indicate these as pathways of soman excretion. Quantitative determinations of radioactivity in various tissue samples were consistent with the above-mentioned findings.

It is concluded that the nature of the persistent binding of soman to lung and skin is striking, and may indicate the existence of specific sites for soman depots.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Boscovic B (1981) The treatment of soman poisoning and its perspective. Fund Appl Toxicol 1: 203–213

    Google Scholar 

  • Clement J (1982) Plasma aliesterase — a possible depot for soman (pinacolyl methylphosphofluoridate) in the mouse. Biochem Pharmacol 31: 4085–4088

    Google Scholar 

  • Ellin RI (1982) Anomalies in the theories and therapy of intoxication by potent organophosphate anticholinesterase compounds. Gen Pharmacol 13: 457–466

    Google Scholar 

  • Fleisher JH, Harris LW (1965) Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphofluoridate. Biochem Pharmacol 14: 641–650

    Google Scholar 

  • Gordon JJ, Leadbeater L, Maidment MP (1978) The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 43: 207–216

    Google Scholar 

  • Hansen D, Schaum E, Wasserman O (1968) Serum levels and excretion of diisopropyl fluorophosphate (DFP) in cats. Biochem Pharmacol 17: 1159–1162

    Google Scholar 

  • Lenz D, Maxwell D, Prather R, Ball L (1983) In vivo determination of 14C-soman in rats. Pharmacologist 25: 111

    Google Scholar 

  • Niden AH (1967) Bronchiolar and large alveolar cell in pulmonary phospholipid metabolism. Science 158: 1323–1324

    Google Scholar 

  • Nordgren I, Lundgren G, Puu G, Holmstedt B (1984) Stereoselectivity of enzymes in toxicity and detoxification of soman. Arch Toxicol 55: 70–75

    Google Scholar 

  • Polak RL, Cohen EM (1969) The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin. Biochem Pharmacol 18: 813–820

    Google Scholar 

  • Polak RL, Cohen EM (1960) The influence of oximes on the distribution of 32P in the body of the rats after injection of 32P-sarin. Biochem Pharmacol 19: 865–876

    Google Scholar 

  • Ramachandran BV (1966) Distribution of DF32P in mouse organs I. The effect of route of administration on incorporation and toxicity. Biochem Pharmacol 15: 169–175

    Google Scholar 

  • Sterri SH, Lyngaas S, Fonnum F (1981) Toxicity of soman after repetitive injections of sublethal doses in guinea-pig and mouse. Acta Pharmacol Toxicol 49: 8–13

    Google Scholar 

  • Ulberg S (1977) The technique of whole body autoradiography: cryosectioning of large specimens. Science Tools (L.K.B. Instrumental Journal), Special Issue

  • Weil CS (1952) Tables for convenient calculation of median effective dose (ID 50 or LD 50) and instruction in their use. Biometrics 8: 249–263

    Google Scholar 

  • Wolthuis OL, Benschop HP, Berends F (1981a) Persistence of the anticholinesterase soman in rats: antagonism with a non-toxic simulor of this organophosphate. Eur J Pharmacol 69: 379–383

    Google Scholar 

  • Wolthuis OL, Berends F, Meeter E (1981b) Problems in the therapy of soman poisoning. Fund Appl Toxicol 1: 183–192

    Google Scholar 

  • Yamada S, Isogai M, Okudaira H, Hayashi E (1983) Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. J Pharmacol Exp Ther 226: 519–525

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kadar, T., Raveh, L., Cohen, G. et al. Distribution of 3H-soman in mice. Arch Toxicol 58, 45–49 (1985). https://doi.org/10.1007/BF00292616

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00292616

Key words

Navigation